Home > Healthcare > Drug Device Combination > Drug Filled Devices > Mucosal Atomization Device Market
Mucosal Atomization Device Market Size
- Report ID: GMI9181
- Published Date: Apr 2024
- Report Format: PDF
Mucosal Atomization Device Market Size
Mucosal Atomization Device Market size was valued at USD 712.3 million in 2023 growing at a CAGR of 7.4% between 2024 and 2032. The market growth is being fuelled by several key factors, including the rising prevalence of respiratory illnesses, expanding adoption of intranasal drug delivery systems, and a surging demand for safer and pain-free medication administration solution. Furthermore, the ease of handling and precise drug delivery facilitated by mucosal atomization devices are bolstering market expansion efforts.
With the increasing prevalence of respiratory conditions such as chronic sinusitis, allergic rhinitis, asthma, and respiratory infections, there is a growing need for effective delivery methods for respiratory medications. Mucosal atomization devices provide a targeted medication delivery method that directly applies the drugs to the respiratory mucosa, enhancing the treatment results for patients with respiratory conditions. According to a study published in National Library of Medicine in April 2022, prevalence of allergic rhinitis has increased globally since the 1990 affecting about 400 million people worldwide yearly.
| Report Attribute | Details |
|---|---|
| Base Year: | 2023 |
| Mucosal Atomization Device Market Size in 2023: | USD 712.3 Million |
| Forecast Period: | 2024 to 2032 |
| Forecast Period 2024 to 2032 CAGR: | 7.4% |
| 2032 Value Projection: | USD 1.3 Billion |
| Historical Data for: | 2021 - 2023 |
| No. of Pages: | 190 |
| Tables, Charts & Figures: | 291 |
| Segments covered: | Product Type, Technology, End User, and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Frequently Asked Questions (FAQ) :
Mucosal Atomization Device Market Scope
